NCT06532084 2024-08-01SoraGVLSt. Petersburg State Pavlov Medical UniversityPhase 2 Recruiting88 enrolled
NCT03878524 2024-03-04Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME TrialOHSU Knight Cancer InstitutePhase 1 Terminated2 enrolled
NCT01445080 2021-02-02Sorafenib in Treating Young Patients With Relapsed or Refractory Solid Tumors or LeukemiaNational Cancer Institute (NCI)Phase 1/2 Completed70 enrolled 26 charts